Best-paid executive in Germany is a Spanish womanBelén Garijo, Merck KGaA’s pharma head, is the best-paid executive in Germany according to the country’s financial journal Handelsblatt, dailies ABC, La Razón and La Vanguardia reported on Saturday. A number of regional newspapers carried the story at the weekend.
Russia’s Kraspharma to invest in AndalusiaKraspharma plans to open a manufacturing plant in Cordoba, Andalusia, dailies ABC, 20 Minutos, La Vanguardia, financial El Economista and a number of regional newspapers reported on Thursday.
Merck & Co 'most admired' pharma because of innovation initiativesMerck & Co's capacity for innovation has made it the highest-ranking pharmaceutical firm in the ‘World’s Most Admired Companies’ list published by Fortune magazine, financial El Economista and medical journal Redacción Médica reported on Thursday.
AstraZeneca among 100 'most sustainable' companiesCanadian investment consulting group Corporate Knights has included AstraZeneca in its ranking of the 100 most sustainable companies in the world, financial El Economista, medical journals Redacción Médica and Acta Sanitaria report on Friday.
Former Lilly executive appointed U.S. secretary of healthAlex Azar, former head of operations for Eli Lilly in the U.S., has been appointed the next secretary of health and human services, medical journal Redacción Médica reports on Friday.
TRY APM HEALTH EUROPE AND GET ACCESS TO THE FULL CONTENT
Interviews with KOLs/senior executives amongst the Regulators, Payers, Health, Medical & Pharmaceutical organisations
Events coverage with a unique focus on Market Access & sustainability of healthcare systems
6 European bureaus : Berlin, Brussels, London, Madrid, Milan & Paris
Ask for a Free trial and get access to our last stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.